BGI Genomics Co., Ltd. (SHE:300676)

China flag China · Delayed Price · Currency is CNY
50.61
-1.64 (-3.14%)
Aug 14, 2025, 2:45 PM CST
39.23%
Market Cap 20.06B
Revenue (ttm) 3.72B
Net Income (ttm) -967.79M
Shares Out 383.85M
EPS (ttm) -2.34
PE Ratio n/a
Forward PE 727.72
Dividend 0.10 (0.19%)
Ex-Dividend Date Jul 4, 2024
Volume 11,036,984
Average Volume 9,422,973
Open 53.22
Previous Close 52.25
Day's Range 50.30 - 53.22
52-Week Range 33.75 - 70.30
Beta 0.72
RSI 43.10
Earnings Date Aug 23, 2025

About BGI Genomics

BGI Genomics Co., Ltd. provides genomic sequencing and proteomic services in China and internationally. The company offers solutions to various applications, such as basic research covering human, plant, animal, and microbial species; clinical research in human health; genetic testing and screening; drug discovery and development; and agriculture and biodiversity preservation and sustainability. It provides DNA, RNA, and customized sequencing solutions; and mass spec services, as well as COVID-19 PCR test kits and COVID lab solutions. In additi... [Read more]

Sector Healthcare
Founded 1999
Employees 3,702
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300676
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.